| Literature DB >> 30230945 |
Jie Shen1, Wei Zhou2, Nan Bi3, Yong-Mei Song2, Fu-Quan Zhang1, Qi-Min Zhan2, Lv-Hua Wang3.
Abstract
Small cell lung cancer (SCLC) is a highly aggressive disease and miRNAs may play an important role in modulating SCLC progression. We have previously screened 924 miRNAs and found that miR-886-3P was negatively associated with SCLC survival. In the current study, we further investigated the role of miR-886-3P mimic in regulating SCLC cell phenotypic alteration in vitro and xenograft tumor formation in vivo. We found that transfection of miR-886-3P mimic significantly inhibited SCLC cell proliferation, migration, and colony formation, and induced mesenchymal-epithelial transition (MET) by suppressing TGF-ß1 synthesis in vitro. Furthermore, intra-tumor injection of miR-886-3P mimic lead to necrosis and suppression of tumor invasion to the surrounding tissue in the subcutaneous xenograft tumor, and intra-vein injection of miR-886-3P mimic suppressed xenograft lung cancer growth in vivo. These findings suggested that miR-886-3P functions as a tumor suppressor in SCLC and thus, it might be a potential therapeutic molecule in the treatment of lung cancer.Entities:
Keywords: Small cell lung cancer; TGF-ß1; aggressive disease; cancer biology; fetal bovine serum; miR-886-3P; miRNAs; pGL3-luciferase
Mesh:
Substances:
Year: 2018 PMID: 30230945 PMCID: PMC6301808 DOI: 10.1080/15384047.2018.1491505
Source DB: PubMed Journal: Cancer Biol Ther ISSN: 1538-4047 Impact factor: 4.742